ProfileGDS4718 / 228956_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 93% 92% 45% 92% 95% 89% 86% 92% 92% 94% 96% 89% 89% 87% 90% 93% 95% 86% 93% 52% 94% 93% 95% 94% 91% 85% 92% 85% 93% 92% 93% 91% 92% 93% 79% 91% 90% 92% 94% 11% 95% 94% 84% 81% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]9.7522893
GSM549102patient 115, normal, homogenized [OPG study]9.5761192
GSM549104patient 119, normal, homogenized [OPG study]5.2327945
GSM549108patient 138, normal, homogenized [OPG study]9.4843292
GSM549119patient 077, normal, homogenized [OPG study]10.222395
GSM549133patient 032, cancer, homogenized [OPG study]9.1854289
GSM549139patient 042, cancer, homogenized [OPG study]8.6295886
GSM549099patient 107, normal, homogenized [OPG study]9.5115292
GSM549109patient 139, normal, homogenized [OPG study]9.5691692
GSM549110patient 046, normal, homogenized [OPG study]10.080194
GSM549114patient 063, normal, homogenized [OPG study]10.656996
GSM549122patient 082, normal, homogenized [OPG study]9.0336989
GSM549134patient 033, cancer, homogenized [OPG study]9.1254689
GSM549136patient 036, cancer, homogenized [OPG study]8.8616687
GSM549140patient 044, cancer, homogenized [OPG study]9.2504990
GSM549111patient 047, normal, homogenized [OPG study]9.8499893
GSM549113patient 057, normal, homogenized [OPG study]10.326595
GSM549132patient 031, cancer, homogenized [OPG study]8.6551386
GSM549137patient 038, cancer, homogenized [OPG study]9.7272293
GSM549142patient 047, cancer, homogenized [OPG study]5.7744452
GSM549100patient 110, normal, homogenized [OPG study]10.104594
GSM549107patient 135, normal, homogenized [OPG study]9.7570693
GSM549115patient 068, normal, homogenized [OPG study]10.36295
GSM549116patient 072, normal, homogenized [OPG study]10.119194
GSM549120patient 078, normal, homogenized [OPG study]9.3762791
GSM549131patient 030, cancer, homogenized [OPG study]8.5827685
GSM549118patient 074, normal, homogenized [OPG study]9.623692
GSM549129patient 027, cancer, homogenized [OPG study]8.4722685
GSM549123patient 088, normal, homogenized [OPG study]9.8021993
GSM549124patient 006, cancer, homogenized [OPG study]9.4476292
GSM549126patient 015, cancer, homogenized [OPG study]9.6206193
GSM549128patient 025, cancer, homogenized [OPG study]9.3062791
GSM549103patient 117, normal, homogenized [OPG study]9.56892
GSM549117patient 073, normal, homogenized [OPG study]9.9923793
GSM549138patient 041, cancer, homogenized [OPG study]7.8437579
GSM549141patient 045, cancer, homogenized [OPG study]9.4365791
GSM549130patient 028, cancer, homogenized [OPG study]9.0482690
GSM549101patient 111, normal, homogenized [OPG study]9.5845892
GSM549105patient 128, normal, homogenized [OPG study]9.8932894
GSM549106patient 134, normal, homogenized [OPG study]3.7668211
GSM549112patient 048, normal, homogenized [OPG study]10.236995
GSM549125patient 011, cancer, homogenized [OPG study]9.8208694
GSM549127patient 024, cancer, homogenized [OPG study]8.3308884
GSM549135patient 035, cancer, homogenized [OPG study]8.0685381